Alexandra Balcom
Vermögen: 9 Mio $ am 31.05.2026
Vermögen: 9 Mio $ am 31.05.2026
Ms. Alexandra Balcom is an Independent Director at Crescent Biopharma, Inc. and a Chief Financial Officer & Treasurer at Nuvalent, Inc. She is on the Board of Directors at Crescent Biopharma, Inc. Ms. Balcom was previously employed as a Vice President-Finance by SQZ Biotechnologies Co. and a Controller by Agios Pharmaceuticals, Inc. She also served on the board at Crescent Biopharma, Inc. (Old).
She received her undergraduate degree from the University of Massachusetts and an MBA from Boston College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,12 % | 01.07.2026 | 85 533 ( 0,12 % ) | 9 Mio $ | 31.05.2026 |
-.--% | 02.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVALENT, INC. | Finanzdirektor/CFO | 01.01.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| SQZ BIOTECHNOLOGIES COMPANY | Corporate Officer/Principal | 01.03.2021 |
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
SQZ Biotechnologies Co.
SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen